One of the major talking points from the MS Virtual 2020 conference was the results from a recent clinical trial testing a potential remyelination therapy, called bexarotene. We had the pleasure of talking to Dr Will Brown, from the University of Cambridge, about this study and the future of myelin repair in multiple sclerosis. We thank Will for generously volunteering his time for this discussion.
If you have questions on any aspects of this interview, please comment below or email them directly to Brett at brett@mstranslate.com.au.
Learn more about MStranslate via the below links:
Website: mstranslate.com.au
Facebook: / mstranslate
Twitter: / mstranslate
Instagram: / mstranslate
LinkedIn: / mstranslate
27 июл 2024